Embolism venous and Memory loss

Summary:

Memory loss is found among people with Embolism venous, especially for people who are female, 60+ old.

The study analyzes which people have Memory loss with Embolism venous. It is created by eHealthMe based on reports of 36 people who have Embolism venous from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Embolism venous?

Embolism venous (embolus may pass into the arterial system) is found to be associated with 307 drugs and 392 conditions by eHealthMe. Check the latest studies of Embolism venous.

What is Memory loss?

Memory loss is found to be associated with 2,730 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.



On Jul, 04, 2026

36 people who have Embolism Venous and Memory Loss are studied.

Would you have Memory loss when you have Embolism venous?

Gender of people who have Embolism Venous and experienced Memory Loss *:

  • female: 75 %
  • male: 25 %

Age of people who have Embolism Venous and experienced Memory Loss *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 4.35 %
  • 40-49: 8.7 %
  • 50-59: 8.7 %
  • 60+: 78.26 %

Common co-existing conditions for these people *:

  1. Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 19.44%
  2. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 7 people, 19.44%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 16.67%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.56%
  5. Affective Disorder (mental disorder): 2 people, 5.56%
  6. Type 2 Diabetes: 1 person, 2.78%
  7. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 2.78%
  8. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 1 person, 2.78%
  9. Rectosigmoid Cancer (cancer that originates in the rectum and sigmoid colon): 1 person, 2.78%
  10. Pain: 1 person, 2.78%

Common drugs taken by these people *:

  1. Eliquis: 14 people, 38.89%
  2. Xarelto: 13 people, 36.11%
  3. Apixaban: 5 people, 13.89%
  4. Amlodipine: 4 people, 11.11%
  5. Potassium: 3 people, 8.33%
  6. Metformin: 3 people, 8.33%
  7. Mercaptopurine: 2 people, 5.56%
  8. Dexamethasone: 2 people, 5.56%
  9. Dapsone: 2 people, 5.56%
  10. Methotrexate: 2 people, 5.56%

Common symptoms for these people *:

  1. Confusional State: 5 people, 13.89%
  2. Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 4 people, 11.11%
  3. Headache (pain in head): 3 people, 8.33%
  4. Dizziness: 3 people, 8.33%
  5. Arthropathy: 3 people, 8.33%
  6. Muscle Spasms (muscle contraction): 2 people, 5.56%
  7. Nervousness: 2 people, 5.56%
  8. Fall: 2 people, 5.56%
  9. Fatigue (feeling of tiredness): 2 people, 5.56%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Memory loss:

All the conditions that are associated with Memory loss:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Memory loss and Embolism venous, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: